TSP-1 increases autophagy level in cartilage by upregulating HSP27 which delays progression of osteoarthritis

Haoqian Li,Lingan Huang,Ruipeng Zhao,Gaige Wu,Yukun Yin,Chengming Zhang,Pengcui Li,Li Guo,Xiaochun Wei,Xianda Che,Lu Li
DOI: https://doi.org/10.1016/j.intimp.2023.111475
IF: 5.714
2024-01-07
International Immunopharmacology
Abstract:This study aimed to determine whether Thrombospondin-1 (TSP-1) can be used as a biomarker to diagnose early osteoarthritis (OA) and whether it has a chondroprotective effect against OA. We examined TSP-1 expression in cartilage, synovial fluid, and serum at different time points after anterior cruciate ligament transection (ACLT) surgery in rats. Subsequently, TSP-1 was overexpressed or silenced to detect its effects on extracellular matrix (ECM) homeostasis, autophagy level, proliferation and apoptosis in chondrocytes. Adenovirus encoding TSP-1 was injected into the knee joints of ACLT rats to test its effect against OA. Combined with proteomic analysis, the molecular mechanism of TSP-1 in cartilage degeneration was explored. Intra-articular injection of an adenovirus carrying the TSP-1 sequence showed chondroprotective effects against OA. Moreover, TSP-1 expression decreases with OA progression and can effectively promote cartilage proliferation, inhibit apoptosis, and helps to sustain the balance between ECM anabolism and catabolism. Overexpression of TSP-1 also can increase autophagy by upregulating Heat Shock Protein 27 (HSP27, hspb1), thereby enhancing its effect as a stimulator of autophagy. TSP-1 is a hopeful strategy for OA treatment.
pharmacology & pharmacy,immunology
What problem does this paper attempt to address?